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Abstract
Inflammatory bowel disease (IBD) is traditionally con-
sidered to be common in the Western world, and its 
incidence has sharply increased since the early 1950s. 
In contrast, until the last decade, low prevalence and 
incidence rates have been reported from other parts of 
the world including Eastern Europe, South America, Asia 
and the Pacifi c region. Recent trends indicate a change 
in the epidemiology of IBD with previously low incidence 
areas now reporting a progressive rise in the incidence, 
while in West European and North American countries 
the figures have stabilized or slightly increased, with 
decreasing incidence rates for ulcerative colitis. Some of 
these changes may represent differences in diagnostic 
practices and increasing awareness of the disease. The 
quality of studies is also variable. Additional epidemio-
logic studies are needed to better defi ne the burden of 
illness, explore the mechanism of association with envi-
ronmental factors, and identify new risk factors.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
The pathogenesis of  ulcerative colitis (UC) and Crohn’s 
disease (CD) is only partly understood. Infl ammatory bowel 
disease (IBD) is a multifactorial disease with probable 
genetic heterogeneity. In addition, several environmental 
risk factors contribute to the pathogenesis. During the 
past decades, the incidence pattern of  both diseases has 
changed dramatically, showing some common but also 
quite distinct characteristics of  the two disorders. Differ-
ences in geographic distribution, and particularly changes 
in incidence over time within one area, may provide insight 
into possible etiological factors[1]. 
    Several studies have been conducted on the epidemiol-
ogy of  IBD[1-3]. The geographical incidence of  IBD varies 
considerably. The highest incidence rates are tradition-
ally reported in Northern and Western Europe as well 
as North America, whereas lower rates are recorded in 
Africa, South America and Asia, including China[2]. It is 
more common in developed, more industrialized coun-
tries, pointing at urbanization as a potential risk factor. The 
incidence rate of  UC varies greatly between 0.5-24.5/105 
inhabitants, while that of  Crohn’s disease varies between 
0.1-16/105 inhabitants worldwide, with prevalence rates of  
IBD reaching up to 396/105 inhabitants. Recent data from 
South Europe[3], East Europe[4] and Asia[5] in the mid-1990s 
report a rise in incidence values in some areas already com-
parable to rates reported from Northern Europe or North 
America. The gap between areas with conventionally high 
and low incidence rates is diminishing. A further difference 
is that the previously reported predominance of  UC is di-
minishing, as CD is becoming more prevalent[6].
INCIDENCE IN THE WESTERN WORLD: 
NORTH/WEST EUROPE AND NORTH AMERICA
The fi rst assessment of  the incidence of  IBD was carried 
out retrospectively in Rochester, Minnesota[7]. The report-
ed incidence of  Crohn’s disease was 1.9/105 in 1935-1954. 
The incidence rates began to increase in the late 1930s in 
the United States and in the 1950s in North and Western 
Europe. From the 1960s onwards, an increasing number 
of  studies of  Crohn’s disease and ulcerative colitis have 
been published. Most of  these studies investigated the 
incidence retrospectively over rather short time periods 
and in small populations. Many of  these studies were 
limited by incomplete case ascertainment. 
    The increase in the incidence of  ulcerative colitis pre-
cedes the increase in the incidence of  Crohn’s disease by 
about 15-20 years. In the late 1990s, the incidence of  UC 
leveled off  to a plateau or even decreased[6], while the 
incidence of  CD was still increasing in most European 
countries. Recent data, however, suggest a further increase 
in the incidence of  IBD, at least in some North European 
countries. The prevalence of  Crohn’s disease in North 
America ranges from 26.0 to 198.5 cases per 105 persons. 
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The incidence rates range from 3.1 to 14.6 cases per 105 
persons[1,7]. That of  UC varied between 6.0 and 14.3 from 
1981 to 1994. Both ulcerative colitis and Crohn’s disease 
appear to be more frequent in the northern parts of  the 
US than in the south.
    Similarly, previous studies in Northern and Western Eu-
rope in the 1970s and 1980s suggested that the incidence 
is decreasing from north to south[8-11], but in the early 
nineties, the European IBD Study Group found compa-
rable rates between Southern and Northern Europe[3]. 
During the period between October 1991 and October 
1993, twenty European centers in twelve countries pro-
spectively collected all newly diagnosed IBD patients, in 
a population-based manner using a standard protocol for 
case ascertainment. The overall incidence was 10.4/105 for 
ulcerative colitis (northern centers: 11.8/105 vs southern 
centers: 8.7/105) and 5.6/105 for Crohn’s disease (7.0/105 
vs 3.9/105). For UC, the highest incidence was found in 
Iceland and the lowest in southern Portugal. For CD, the 
highest incidence rates were observed in the southeastern 
Netherlands and in northwestern France. Nonetheless, the 
excess in northern centers was less pronounced than previ-
ously reported. Similarly, gradually increasing incidence val-
ues were reported from Italy between 1978 and 1992 (from 
3.8/105 to 9.6/105 for UC and from 1.9/105 to 3.4/105 
for CD) in the well-known Florence study[8]. In addition, 
in recent publications, the incidence rate of  UC in Central 
Greece has been reported to be as high as 11.2/105, similar 
to that observed in high incidence North European centers[9]. 
    In addition, we have to note that continuously increas-
ing incidence values are still reported from some high 
incidence areas, e.g. Denmark and Sweden. Earlier stud-
ies have reported an incidence of  4.1/105 for CD and 
9.2/105 for UC from the 1980s[10], while recent data in 
2003-2005 indicate even higher incidence rates (CD: 
8.6/105, UC: 13.4/105)[11]. In Stockholm, the correspond-
ing incidence data for CD in 1990-2001 were 4.9/105 in 
1985-89 and 8.3/105 in 1990-2001[12]. In contrast, data 
from the UK indicate a plateau with an incidence around 
10.0/105-13.9/105 for UC, while it is still increasing 
(3.9/105-8.3/105) in CD[13].
    A further difference is that the previously reported pre-
dominance of  UC is diminishing, as CD is becoming more 
prevalent. Furthermore, decreasing incidence values in 
1988-1999 were reported from Northern France. The inci-
dence of  CD was increased slightly from 5.2/105-6.4/105, 
while that of  UC decreased from 4.2/105 to 3.5/105 [12].
INCIDENCE OF IBD IN OTHER PARTS OF 
THE WORLD: EAST EUROPE, ASIA AND 
SOUTH AMERICA
Until recently, only limited data was available on the 
epidemiology of  IBD from other parts of  the world. Most 
of  these data are retrospective, hospital based surveys. 
One of  the few exceptions is the study by Vucelic et al[14] 
from Croatia, who conducted a prospective study on the 
incidence of  IBD in Zagreb in 1980-1989. The study was 
population-based, including inpatient and outpatient data, 
as well as general practitioners’ reports. The reported 
incidence rate is 1.5/105 inhabitants for UC and 0.7/105 
for CD. The prevalence of  UC and CD was 21.4/105 and 
8.3/105 respectively at the end of  1989. 
    In the last few years, a signifi cant number of  papers and 
reviews have been published on the epidemiology of  IBD 
from Eastern Europe and Asia[4,5]. However, there is still 
a signifi cant lack of  data from Latin America, Africa and 
Australia. Most of  these studies have reported a change 
in the epidemiology of  IBD. The rise in incidence began 
in the early 1990s, in parallel with changes in governing 
systems and social environment. In Eastern Europe, a 
population-based epidemiology survey from Hungary[15] 
reported a sharp increase in incidence of  UC from 1.7/105 
during 1977-1981 to 11.0/105 during 1997-2001. In CD, a 
similar trend was observed (from 0.4/105 to 4.7/105). The 
ratio of  UC/CD incidence rates decreased from 4.0 to 2.3 
during the observed periods. The prevalence of  UC and 
CD was 142.6/105 and 52.9/105 inhabitants respectively at 
the end of  2001. Similarly, in a prospective study Mijand-
rusic Sincic et al[16] reported much higher rates in Croatia 
(7.0/105 for CD and 4.3/105 for UC) in 2000-2004 com-
pared to previous reports. 
    In contrast, a questionnaire-based nationwide epide-
miological survey[17] from Romania, over a period of  one 
year between June 2002 and June 2003, still reported low 
incidence of  both UC (0.97/105) and CD (0.50/105). Cor-
responding prevalence data were also very low (2.25/105 
in UC and 1.51/105 in CD). Similarly, low incidence was 
reported in a population-based prospective study from 
Estonia[18]. The data were collected between 1993 and 1998 
in Tartu country (151 301 inhabitants) from the internal 
medicine, paediatrics and surgery departments. A total of  
16 UC and 13 CD patients were diagnosed, equalling an 
average incidence of  1.7/105 for UC and 1.4/105 for CD. 
However, the relative small area and small absolute number 
of  patients might have biased the data. 
    Similar trends in UC have been observed in Asia. 
Although both incidence and prevalence rates of  IBD are 
still low compared with Europe and North America, they 
are rapidly increasing. An emergence of  UC is apparent. 
In contrast, the incidence of  CD is still low. An analysis 
of  UC patients from China reported a total of  10 218 
cases from 1981 to 2000[19]. Of  these, 2506 were diagnosed 
between 1981 and 1990, and 7512 between 1991 and 
2000, a three-fold increase. The most recent review [11] 
of  Chinese literature reveals that 143 511 cases of  IBD 
(140 120 of  UC and 3391 of  CD) were described during 
the last 15 years, with an 8.5-fold increase during the last 5 
years compared with the fi rst 5 years. In addition, though 
figures are still low, Leong et al[20] reported a three-fold 
increase in the incidence of  CD in the Chinese population 
of  Hong Kong, from 0.3/105 in 1986-1989 to 1.0/105 
in 1999-2001. A hospital-based study came to the same 
conclusions. An estimated incidence of  0.28/105 and a 
prevalence of  1.38/105 were reported between 1950-2002 
from 22 provinces of  China[21]. 
    Recent reviews from Japan also report an increase in 
the incidence and prevalence of  IBD. Hospital-based 
investigations reported that the incidence of  UC was 
1.95/105, and the prevalence was 18.12/105 in 1991[21]. 
In a retrospective study from Seoul, South Korea, the 
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prevalence of  UC was 7.57/105, with a signifi cant increase 
in incidence rates from 0.20/105 in 1986-1988 to 1.23/105 
in 1995-1997[21]. In Thailand, UC is still uncommon, with 
only 40 cases reported between 1988 and 2000[22].
    Singapore is also witnessing a higher prevalence of  IBD, 
recently estimated at 6/105[23]. The current prevalence of  
UC is 17/105, whereas that of  CD is lower, at 3.6/105. 
The impact of  ethnicity in various Asian populations has 
also been studied in Singapore, a multiracial city-state 
composed of  Chinese, Malay and Indian groups[24]. The 
prevalence of  UC in the three races has been calculated 
to be 6.2/105 for Chinese, 4.8/105 for Malay and 16/105 
for Indian subjects. Similar prevalence data were reported 
from a recent retrospective hospital-based study from 
Kuala Lumpur, Malaysia. The prevalence of  UC was 
17.9/105 in Indians, followed by 11.2/105 in Chinese and 
only 3.7/105 in Malays between 1985 and 1998. No such 
marked difference was seen in CD. The prevalence rates 
in Chinese, Malays and Indians were 4.0/105, 2.9/105 and 
4.9/105, respectively[23]. 
    The lower prevalence and incidence of  IBD in Asia 
compared with the West are not universal. A population-
based study from Nor thern India found that the 
prevalence rate of  UC is 42.8/105[25]. This unexpectedly 
high prevalence has been recently confirmed by another 
population-based study in Punjab, also in Northern India, 
revealing a prevalence of  44.3/105 and an incidence of  
6.02/105[26]. However, a major limitation of  these studies 
is that they only screened a population sample of  around 
22 000 and 52 000 inhabitants, respectively. Thus, the 
results rely on a very small number of  definite cases 
extrapolated to the whole population of  the area.
    IBD in Middle-East is traditionally reported to be high 
among Jews from the United States and Northern Europe. 
In Israel, the incidence is somewhat lower and Ashkenazi 
Jews have a higher incidence than Sephardic Jews. In 2000, 
Niv et al[27] reported an annual incidence of  5.04/105 for 
UC for a ten-year follow-up period between 1987-1999. 
The prevalence rate rose from 121.0/105 to 167.2/105.
    In contrast, Arab countries in the Middle East still re-
port low incidence rates. A prospective hospital-based 
study from Saudi Arabia[28] reported an estimated inci-
dence of  0.5/105 and prevalence of  5.0/105 for IBD in 
children in 1993-2002. Similarly, a retrospective study from 
the same region estimated a 0.94/105 mean incidence of  
CD in 1983-2002, with a gradual increase in incidence 
from 0.32/105 to 1.66/105[29]. In contrast, in Turkey the 
incidence of  UC was as low as 0.59/105-0.69/105 between 
1998 and 2001, in a hospital-based study[30]. Finally, a 
recent case series from Teheran, Iran suggests very low 
incidence rates, since authors reported that only 448 IBD 
patients were referred to or diagnosed in two university 
hospitals and two private GI clinics between 1992 and 
2002[31]. 
    Only limited data are available from Central and South 
America. A recent prospective study has reported the 
incidence of  IBD in Puerto Rico[32]. The total incidence 
of  IBD increased significantly between 1996 and 2000 
(3.07/105 to 7.74/105), being signifi cantly higher than CD. 
In contrast, much lower incidence rates were reported 
from a population-based survey from Panama and 
Argentina[33] in 1987-1993. The annual incidence of  UC 
was 1.2/105 in Panama and 2.2/105 in Argentina, with 
only a single case of  CD being identified. Similarly, the 
incidence of  both UC and CD admissions is low in Brazil 
with only 257 new cases (126 CD and 131 UC) diagnosed 
in 1980-1999[34].
    Finally, Gearry et al[35] have recently reported one of  
the highest incidence rate of  CD from New Zealand 
in 2004. The reported incidence of  CD is 16.5/105 and 
the incidence of  UC is lower (7.6/105). Corresponding 
prevalence rates are 355.2/105 and 145.0/105.
INFLAMMATORY BOWEL DISEASE IN 
CHILDREN AND ELDERLY
It is important but difficult to study the epidemiology 
of  IBD in children. Although both UC and CD are rare 
below the age of  11 years, the incidence of  these diseases 
increases rapidly after adolescence. In the pediatric age 
group, several epidemiologic studies have been published 
with some evidence suggesting that the incidence of  IBD 
(in particular, CD) has increased over the last ten years. 
    The explanation for the differences in incidence be-
tween studies is further complicated by different defini-
tions of  childhood. The upper age limit varies between 14 
and 17 years of  age. Furthermore, upper gastrointestinal 
involvement is reported to be more common in children 
with CD. In addition, we have to note that new diagnostic 
tools may lead to overinterpretation of  IBD emergence, 
since the clinical importance of  minute lesions such as 
small erosions diagnosed during capsule endoscopy or 
double-balloon enteroscopy, which may be often diag-
nosed as IBD in children with abdominal pain, is still to 
be determined. To exclude this possibility, new uniform 
criteria have been developed for the diagnosis of  IBD in 
children by ESPGHAN[36].
    Most of  the published data come from the United 
States and Western Europe. The largest prospective study 
from the United Kingdom and Ireland has reported a well-
characterized cohort of  739 children with IBD[37]. The 
mean incidence of  CD and UC is 3.0/105 and 1.5/105. 
Higher values were reported in a prospective study from 
Wisconsin, United States between 2000 and 2001[38]. The 
mean incidence of  CD and UC is 4.5/105 and 2.1/105, 
respectively.
    A further population-based study from Copenhagen[39] 
reported that 7% of  the 1161 patients diagnosed with UC 
and 6% of  the 373 patients with CD had an onset before 
15 years of  age. The median age at diagnosis was 12 years 
(range 0-14 years), indicating a steep increase in incidence 
around puberty. During the 26 years of  the study, no 
signifi cant change in incidence was found, the mean inci-
dence of  IBD was 2.2/105 (UC: 2.0/105 and CD: 0.2/105). 
In another study of  a large area of  Sweden, Lindberg et al[40] 
prospectively studied all patients below 16 years of  age 
with a diagnosis of  definite or probable UC and CD in 
1984-1995. An increase in the incidence of  UC was found 
(from 1.4/105 to 3.2/105), but only in the age group of  
11-16 years, not in early childhood. The incidence of  CD 
did not change over the time studied.
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    In contrast, other studies have reported a marked in-
crease in the incidence of  pediatric IBD. A slight increase 
in the incidence of  juvenile onset CD was reported from 
Scotland between 1981 and 1995 with marked differences 
in the incidence of  CD between north and south[41]. The 
incidence of  UC and CD increased over the observed pe-
riod in both south (UC: 0.9-1.6/105 and CD: 1.8-2.5/105) 
and north (UC: 0.9-1.8/105 and CD: 2.8-3.5/105) ter-
ritories. Similarly, an increase in the incidence of  CD was 
reported in a prospective study from northern Stockholm 
between 1990 and 2001[42]. The incidence in CD rose 
from 1.5/105 to 8.4/105 (mainly in the age group of  10-15 
years), while that of  UC was relatively stable at approxi-
mately 1.8-1.9/105, except for 1990-1992. One of  the larg-
est studies has been reported from Northern France[43]. In 
a prospective follow-up study, a total of  7066 patients were 
diagnosed, 509 (7.2%) of  them were under the age of  17 
years at the time of  diagnosis. During follow-up, a trend 
for an increase in the incidence of  CD was observed (from 
2.1/105 to 2.6/105), while the incidence of  UC remained 
unchanged (0.8/105).
    In Eastern Europe, Pozler et al[44] have recently pub-
lished the results of  a retrospective study investigating the 
incidence of  CD in the Czech Republic in children diag-
nosed under the age of  15 years between 1990 and 2001. 
A marked increase in the incidence of  CD was reported 
from 0.25/105 in 1990 to 1.25/105 in 2001.
    The same trend has been reported from Melbourne, 
Australia[45] in a retrospective, hospital-based study in chil-
dren diagnosed under the age of  16 years. The incidence 
of  CD rose from 0.13/105 to 2.0/105 between 1971 and 
2001. 
    An interesting question is the incidence of  IBD in 
elderly populations. At least according to the published 
data from Western Europe, it may not be as uncommon 
as previously suspected. A prospective Belgian study[46] 
between 1993 and 1996 reported that the incidence of  
IBD in the elderly population (age at diagnosis > 60 years) 
is high (UC:4.5 and CD:3.5), was comparable to the fi gures 
for younger age groups (UC: 3.4 and CD: 4.8).
    Similarly, comparable incidence rates for CD have been 
reported from France between 1994 and 1997[47]. The an-
nual incidence rate is 2.5/105, with a higher proportion of  
colonic disease. 
HOW CAN WE EXPLAIN THE RECENT 
EPIDEMIOLOGICAL TRENDS?
The incidence of  IBD varies greatly worldwide. Genetic 
and environmental factors are assumed to play a signifi cant 
role in the aetiology of  the disease. The role of  genetic 
factors is supported by ethnic and familial differences as 
well as twin studies[1,4], while the differences in incidence 
rates among various geographical areas suggest a role 
of  certain environmental factors. It is known that the 
incidence differs among different ethnic groups living in 
the same geographic region. This fact is mostly observed 
in Asian countries[5,24]. Similarly, the genetic predisposition 
may have led to the observation that the risk for IBD in 
Asian immigrants surpassed that observed in UK’s native 
population with an odds ratio of  6.1[48]. In addition, disease 
phenotypes may also vary among different races, e.g. in 
a recent study from the United States[49] reported that 
African American CD patients are more likely to develop 
upper gastrointestinal, colorectal or perianal disease, uveitis 
and sacroileitis compared to whites, while Hispanics are 
at higher risk of  developing perianal disease or erythema 
nodosum, supporting a role of  underlying genetic 
variations. Finally, the prevalence of  identifi ed genetic risk 
factors (e.g., NOD2 in CD) is also different in the different 
populations.
    An important change in the incidence of  IBD has taken 
place in the last few decades. In most of  the Western 
Europe countries, the incidence rate remains relatively 
stable or even decreased. In contrast, continuously 
increasing incidence rates of  CD have been recently 
reported from other high incidence areas such as 
Denmark[11] and Sweden[12]. There is also an important 
change in the diagnosis of  CD. A new classification 
system has been developed[50], as well as new tools which 
are readily available for the investigation of  the small-
bowel (e.g., capsule endoscopy[51,52] and double balloon 
enteroscopy[53]), which may lead to a further increase in 
reported incidence rates. As a consequence, an unusually 
high upper gastrointestinal involvement (as high as 55%) 
has been reported in recent genetic studies in pediatric 
settings[54]. A similar trend is also apparent in the adult 
cohorts. Nonetheless, it is important to note that the 
clinical importance of  minute lesions still needs to be 
determined. Capsule endoscopic examinations due to 
abdominal pain can reveal small lesions (angiodysplasias 
and small erosions) in similar percentages of  subjects[55]. 
Since the penalty for false-positive testing is very high 
(unnecessary use of  toxic and expensive medications, 
and the stigma of  being diagnosed with a serious chronic 
disease), at present, capsule endoscopy and double balloon 
endoscopy should be used only in limited clinical situations 
rather than routinely. In addition, the interpretation 
of  microscopic disease, especially in children is rather 
controversial. Nonetheless, this still does not explain the 
higher incidence values reported in recent studies.
    In previously low-incidence areas, especially in Eastern 
Europe[4,15,16] and some regions in Asia[26], the disease has 
become more prevalent. Until now, the role of  private 
practice is limited in Eastern Europe and most Asian 
countries and the majority of  patients are managed in the 
public health care system, enabling population-based epi-
demiological investigations. The diligent collection of  data 
and case ascertainment is, of  course crucial. 
    The increased incidence rates of  both UC and CD ob-
served in Eastern Europe and Asia raise further questions. 
What could be the cause of  this change? In the 1970s and 
early 1980s the lower incidence rates could be partially 
explained by the use of  fewer up-to-date diagnostic pro-
cedures (e.g., the relative low availability of  selective en-
terography or colonoscopy). It is also possible that greater 
awareness, either by physicians or by patients, may result in 
the diagnosis of  mild cases that might have been previously 
unnoticed. There has also been an important change in 
patients’ behaviour, at least in Eastern Europe, as patients 
tend to seek medical advice more often and with milder 
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symptoms than they did two decades ago. In contrast, in 
Eastern Europe, due to various and multiple causes, the 
access to health care services has not improved much. 
The reported incidence rates of  IBD in Hungarian[15] and 
Croatian[16] are in a similar range, as previously observed 
in Nordic countries[3,56,57]. In contrast, other countries (e.g., 
Czech Republic, Poland, Romania and Slovakia) still report 
low incidence rates. These studies however, have several 
limitations. Some of  them were retrospective surveys[44], 
while others were based solely on the in- and outpatient 
records of  a single hospital, extrapolating the results to the 
investigated area[4]. Patients might have been unnoticed, 
thus the incidence rate is clearly underestimated. We be-
lieve that the increase in the incidence of  IBD in Eastern 
Europe in the late 1980s and 1990s is real and not solely 
due to improved diagnosis, better health care access or 
more extensive search. This notion is also supported by 
the increase in more severe cases, which can only be inter-
preted as real. 
    The observed changes may be at least partially explained 
by the differences in study design. Most of  the earlier stud-
ies from Eastern Europe, and still the majority of  studies 
from Asia[19,23], Middle-East[29,30] and Central America[33] 
are biased by methodological shortcomings. A great ma-
jority of  them were retrospective, hospital-based surveys, 
which may have at least partly been responsible for the low 
incidence rates reported. In contrast, recent prospective, 
population-based studies, especially from Eastern Europe 
with extensive search for IBD cases[25,32] have reported 
much higher incidence rates from the same regions with 
some exceptions[20]. The situation is somewhat different 
in India. Though papers are prospective[25,26], results might 
have been biased by methodological problems. Only ques-
tionnaire-based surveys were conducted and only a limited 
population sample was screened. Thus, the results rely on 
a very small number of  defi nite cases extrapolated to the 
whole population of  the area.
    Diet, as a luminal antigen, is thought to be an impor-
tant factor in the pathogenesis of  IBD[1,58]. In the last two 
decades, there has been a change in the lifestyle in Eastern 
Europe, Asia and Central America, as the standard way of  
living, including the diet, has become more “Westernized”. 
This possibility is further supported by the differences 
in incidence and prevalence found within one region. In 
Eastern Europe[4,15], the change in the incidence is parallel 
to the change in governing system and the prevalence is 
clearly different between the more “Western”-type living in 
the western regions, as opposed to the less rapidly chang-
ing eastern parts. 
    This raises the possibility that the prevalence of  IBD, 
e.g., in the eastern parts of  Europe and Asia is also capa-
ble of  changing in the next one or two decades. An early 
signal of  this change might be the reported increase in the 
incidence of  UC in many of  the Asian countries. Since the 
change in incidence of  UC precedes that in CD in most 
countries, it is possible that different environmental factors 
are responsible for the increase in the incidence of  UC and 
CD. Alternatively, the same environmental factors may act 
differently in the two diseases, resulting in different epide-
miological patterns. This is supported by the recent trends 
in the incidence of  UC in Asia and the similar changes in 
the late 1980s and early 1990s in Eastern Europe, where 
the increase in the incidence of  UC precedes that of  CD. 
It is therefore, of  outstanding interest to follow the tem-
poral trends of  IBD epidemiology in Asia, Eastern Europe 
and Central America. In addition, these studies offer a 
unique possibility to extensively study the role of  possible 
environmental risk factors in the susceptibility of  IBD. 
    Other possible environmental factors, such as perinatal 
events, childhood infections or measles have not been in-
vestigated outside North America and Western and North-
ern Europe[59,60]. Measles vaccination is however universal 
in Eastern Europe making the disease very rare, in addition 
to a low birth rate. Early childhood hygiene is also well de-
veloped, supporting a possible role of  the “oversheltered 
child” theory[61]. The hygiene hypothesis suggests that 
skewing of  the Th1/Th2 balance in early life is a major 
cause for the recent increase in allergic and autoimmune 
diseases. Recent data from different regions of  Canada 
have controversial results[62,63]. Nonetheless, since early 
and high level of  childhood hygiene has existed, at least in 
Eastern Europe since the early 1970s, it does not explain 
the epidemiological trend observed in the late 1990s. In 
addition, the reported prevalence of  other known environ-
mental factors (e.g., smoking, frequency of  appendectomy, 
contraceptive and use of  NSAID and antibiotics) did not 
change signifi cantly in the last decades, thus it is unlikely 
that these factors are essential in evolution of  the epidemi-
ology trends. 
    The incidence of  IBD varies greatly worldwide. In tra-
ditionally high incidence areas, e.g. in West European and 
North American countries the figures have stabilized or 
slightly increased, with even decreasing incidence rates 
for ulcerative colitis. In contrast, low prevalence and in-
cidence rates have been reported from other parts of  the 
world including Eastern Europe, South America, Asia and 
the Pacifi c region. Recent trends however, also indicate a 
change in the epidemiology in these countries, since previ-
ously low incidence areas are now reporting a progressive 
rise in the incidence. Some of  these changes may represent 
differences in diagnostic practices and increased awareness 
of  the disease. The quality of  the surveys is also variable. 
Most probably, inadequately identifi ed environmental fac-
tors or a combination of  these factors may be responsible 
for the recent rapid changes. Additional epidemiologic 
studies are needed to better defi ne the burden of  illness, 
explore the mechanism of  association with environmental 
factors, and identify new risk factors. 
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